Ketogenic Diet and Neuromodulation in Treatment Resistant Depression
NCT07376018 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2026-08-07
Summary
The goal of this clinical trial is to learn if combining a ketogenic diet with a personalized, accelerated brain stimulation treatment (iTBS) works better than iTBS with a standard healthy diet to reduce depression symptoms in adults with treatment-resistant depression. The main questions it aims to answer are:
* Does iTBS combined with a ketogenic diet improve depression symptoms more than iTBS combined with a standard healthy diet?
* Does the ketogenic diet change ketone levels over time?
* Is it safe, tolerable, and feasible to follow a ketogenic diet during accelerated iTBS treatment?
We will compare a ketogenic diet to a Canadian Food Guide-aligned diet, both combined with iTBS, measuring depression severity using standard clinician-rated and self-report scales.
Participants will:
* Follow either a ketogenic diet or a standard healthy diet for 12 weeks, starting with a 3-week lead-in period before iTBS begins
* Undergo a course of personalized, imaging-guided accelerated iTBS while continuing their assigned diet
* Complete clinical and cognitive assessments, blood tests, and brain MRI scans before and after treatment
* Have their ketone levels checked regularly throughout the 12-week period
Conditions
- Major Depressive Disorder (MDD)
- Treatment Resistant Depression (TRD)
Interventions
- DEVICE
-
Accelerated Intermittent Theta Burst Stimulation (iTBS)
Intermittent theta burst stimulation (iTBS), a form of repetitive transcranial magnetic stimulation (rTMS), is a non-invasive brain stimulation technique approved by the FDA and Health Canada for the treatment of TRD. In this study, participants will receive an accelerated course of imaging-guided, neuronavigated left dorsolateral prefrontal cortex (DLPFC) iTBS targeted based on functional connectivity with the subgenual anterior cingulate cortex (sgACC). Stimulation protocol consists of 1800 pulses per session, delivered at 110% of resting motor threshold, with 50-minute inter-session intervals, for 8 sessions per day over 5 consecutive days.
- BEHAVIORAL
-
Ketogenic Diet
A well-formulated ketogenic diet consisting of low carbohydrate, moderate protein, and high fat intake, designed to achieve and maintain nutritional ketosis (blood ketone levels of 0.5 to 3 mmol/L). Delivered with dietitian-led counseling and monitored via finger-stick ketone and glucose testing.
- BEHAVIORAL
-
Canadian Food Guide-Aligned Diet
A Canadian Food Guide-aligned diet emphasizing balanced intake of vegetables, fruits, whole grains, and protein foods, without specific macronutrient restrictions. Delivered with dietitian counseling matched in frequency and duration to the ketogenic diet arm, and monitored via dietary logs, metabolic assessments, and finger-stick glucose testing.
Sponsors & Collaborators
-
Baszucki Group
collaborator UNKNOWN -
Sunnybrook Health Sciences Centre
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-08-31
- Primary Completion
- 2028-01-31
- Completion
- 2028-01-31
Countries
- Canada
Study Locations
More Related Trials
-
Nebulized Ketamine for the Treatment of Major Depressive Disorder
NCT06752759 ·Status: RECRUITING ·Phase: PHASE3
-
Ketogenic Diet for Depression
NCT06105762 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Psychotherapy Combined With Intranasal Esketamine for the Treatment of Suicidal Ideation
NCT07396220 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
IV Ketamine Vs. in Esketamine for MDD TRD
NCT06488586 ·Status: RECRUITING
-
Safety and Effectiveness Study of BCI-540 Versus Placebo in the Treatment of Major Depressive Disorder With Concomitant Anxiety
NCT00621270 ·Status: COMPLETED ·Phase: PHASE2
-
Administration of Subanesthetic Dose of Ketamine and Electroconvulsive Treatment for Treatment Resistant Depression
NCT02522377 ·Status: COMPLETED ·Phase: NA
-
Behavioural Activation Therapy and Esketamine for Resistant Depression
NCT06431386 ·Status: TERMINATED ·Phase: NA
-
A Study of Brexpiprazole Plus Ketamine in Treatment-Resistant Depression (TRD)
NCT03149991 ·Status: COMPLETED ·Phase: PHASE4
-
Ketamine-Assisted Psychotherapy for Treatment-Resistant Depression
NCT07247006 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Study of Ketamine in Patients With Treatment-resistant Depression
NCT01627782 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of a Keto-Like Supplement on Brain Responses to Emotional Stimuli in Depression
NCT06263660 ·Status: RECRUITING ·Phase: PHASE2
-
NRX100 vs. Placebo for Rapid Stabilization of Acute Suicidal Ideation and Behavior in Bipolar Depression
NCT03396601 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Double-Blind, Placebo-Controlled Trial of Ketamine Therapy in Treatment-Resistant Depression (TRD)
NCT01920555 ·Status: COMPLETED ·Phase: PHASE2
-
Memory Functioning and Antidepressant Treatment
NCT00296933 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Trial of Add-on Oral Slow-release Ketamine Treatment in Major Depression
NCT07396272 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Ketamine for Treatment Resistant Late-Life Depression
NCT02556606 ·Status: COMPLETED ·Phase: PHASE3
-
Intravenous Ketamine for Treatment-Resistant Depression
NCT06668571 ·Status: RECRUITING ·Phase: PHASE2
-
Effect of Bupropion on Seizure Threshold in Depressed Patients
NCT03126682 ·Status: COMPLETED ·Phase: PHASE4
-
Ketamine for Major Depressive Disorder
NCT03721900 ·Status: UNKNOWN ·Phase: PHASE1
-
Predictors of Intravenous Ketamine Response in TRD
NCT05625555 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Ketamine Infusion for Treatment-resistant Major Depressive Disorder
NCT01582945 ·Status: COMPLETED ·Phase: NA
-
Intranasal Ketamine in Ultra-REsistant Depression (SURE-ECT Non Responders)
NCT05137938 ·Status: COMPLETED ·Phase: NA
-
Cognitive Training as an Adjunct to Ketamine in Real-world Clinics
NCT06526078 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Ketamine in Adolescents With Treatment-Resistant Depression
NCT02078817 ·Status: COMPLETED ·Phase: PHASE2
-
Optimization of IV Ketamine for Treatment Resistant Depression
NCT00768430 ·Status: COMPLETED ·Phase: PHASE2